Home › Immune System and Disorders › Illinois
Immune System and Disorders clinical trials in Illinois
9 studies for Immune System and Disorders are looking for participants at sites in Illinois.
Cities in Illinois
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- and 49 more
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- University of Illinois Hospital & Health Sciences System, Chicago
RecruitingPhase 1/2
Ages 35 to 70 · All sexes · Updated Aug 21, 2026 · NCT06575426A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- University of Chicago Medical Center, Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 2, Rolling Meadows
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Northwestern University, Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Northwestern Memorial Hospital, Chicago
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078Study of Gastric Motility in Eosinophilic Gastritis
- Northwestern University, Chicago
RecruitingObservational study
Ages 18 to 59 · All sexes · Updated Mar 31, 2026 · NCT05229432A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- University of Illinois Medical Center - Hematology & Oncology, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- University of Chicago, Chicago
RecruitingPhase 4
All ages · All sexes · Updated May 14, 2009 · NCT00004317From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.